H

Hugel Inc
KOSDAQ:145020

Watchlist Manager
Hugel Inc
KOSDAQ:145020
Watchlist
Price: 271 000 KRW -2.34% Market Closed
Market Cap: 3T KRW
Have any thoughts about
Hugel Inc?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

14.8
Current
9.9
Median
4.2
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
14.8
=
Enterprise Value
2.6T KRW
/
EBITDA
172.6B KRW
All Countries
Close
Market Cap EV/EBITDA
KR
Hugel Inc
KOSDAQ:145020
3T KRW 14.8
FR
Pharnext SCA
OTC:PNEXF
6T USD -219 796.6
US
Abbvie Inc
NYSE:ABBV
312.7B USD 15.3
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 17.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.2B USD 24.1
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 9.9
US
Epizyme Inc
F:EPE
94.1B EUR -514.1
AU
CSL Ltd
ASX:CSL
133.6B AUD 20.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD 15.9
US
Seagen Inc
F:SGT
39.3B EUR -58.7
NL
argenx SE
XBRU:ARGX
34.8B EUR -105.5
EBITDA Growth
KR
H
Hugel Inc
KOSDAQ:145020
Average EV/EBITDA: 16.8
14.8
113%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.9
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.5 N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
14
2-Years Forward
EV/EBITDA
11.1
3-Years Forward
EV/EBITDA
9.1

See Also

Discover More